MedPath

The Clinical Safety of Alcoholic Extract Sahastara Remedy of Extract Capsule in Healthy Volunteers

Phase 1
Completed
Conditions
Osteoarthritis
Interventions
Drug: Sahastara remedy alcoholic extract
Registration Number
NCT02568059
Lead Sponsor
Thammasat University
Brief Summary

The clinical safety of Sahastara remedy alcoholic extract in healthy volunteers. Investigators will investigate safety of 100 and 200 mg of Sahastara remedy extract capsule in healthy volunteers. This is Clinical trial Phase I.

Detailed Description

The sahastara remedy (SHT) is a Thai traditional medicine that is use to relieve pain of musculoskeletal problem. There is study shown that SHT extract was not found acute and chronic toxicity in rat. However, there is no study regarding safety in human. Thus, this study is a clinical trial Phase I that investigate clinical safety of SHT alcoholic extract in healthy volunteers. The clinical safety will monitor for 28 days in continuously use of 100 and 200 mg SHT extraction 3 time a day and after stop intervention for 14 days.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • No pregnancy
  • No Serious Medical Condition evaluated by Physical Examination and Laboratory results in 1 month before study
  • No Supplementary food and/or Vitamin during the study
  • Able to follow suggestion during the study
Exclusion Criteria
  • Uncontrolled Hypertension (BP>140/90 mm.Hg.)
  • BMI > 30
  • Have serious medical condition including Severe peptic ulcer, congestive heart disease, Liver and Renal dysfunction.
  • On during use medicine including Rifampicin, Phenytoin, Propranolol, Theophylline

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
200 mg SHT extractSahastara remedy alcoholic extractThe Sahastara remedy alcoholic extract capsule dose 200 mg.
100 mg SHT extractSahastara remedy alcoholic extractThe Sahastara remedy alcoholic extract capsule dose 100 mg.
Primary Outcome Measures
NameTimeMethod
Clinical safety evaluated by History taking, Patient diary note, Physical Examination and Laboratory test including Complete Blood Count (CBC), Renal functions, Liver functions, Lipid profile, Fasting Blood Sugar (FBS), and Urinary analysis14 days after stop intervention

Clinical safety was evaluated changing from baseline,14 days and 28 days while using intervention by History taking, Patient diary note, Physical Examination and Laboratory test including Complete Blood Count (CBC), Renal functions, Liver functions, Lipid profile, Fasting Blood Sugar (FBS), and Urinary analysis

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of Medicine, Thammasat University

🇹🇭

Klongnueng, Pathumthani, Thailand

© Copyright 2025. All Rights Reserved by MedPath